Market Cap

MedMira, Inc. Market Capitalization:

€30.3 Million

EUR as of Jan. 1, 2026

US$35.5 Million

business MedMira, Inc. Company Profile

MedMira, Inc. Main Stock Listing

FSX: 47M

Market Capitalization History of MedMira, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of MedMira, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 €30.3 M -54.60%
Jan. 1, 2025 €66.7 M 33.09%
Jan. 1, 2024 €50.1 M -19.54%
Jan. 1, 2023 €62.3 M -40.35%
Jan. 1, 2022 €104.4 M -39.68%
Jan. 1, 2021 €173.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

MedMira, Inc. Categories

Canada languages Healthcare languages Biotechnology
Canada Healthcare Canada Biotechnology

Stocks & Indices

MedMira, Inc. has the following listings and related stock indices.


Stock: FSX: 47M

Stock: OTC: MMIRF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.